Clinical Trial Update: Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update covers a Phase 1/2 study of Panitumumab with Rilotumumab or Ganitumab in KRAS wild-type metastatic colorectal cancer, which has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Ganitumab (ganitumab)
• Panitumumab (panitumumab)
• Rilotumumab (rilotumumab)

Snippet

Sponsor: NantBioScience, Inc. | Conditions: Colon Cancer, Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-07-20